Biocon Ltd BIOCON Financial and Strategic SWOT Analysis Review [Report Updated: 18072017] Prices from USD $125

16:38 EDT 1 Aug 2017 | BioPortfolio Report Blog

Biocon Ltd BIOCON Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Biocon Ltd Biocon is a global biopharmaceutical company specialized in biopharmaceuticals and research services. The company produces a wide range of active pharmaceutical ingredients APIs, branded formulations; and complex biologics both novels and biosimilars including monoclonal antibodies MAbs, rhInsulin and insulin analogs. Its core therapeutic areas include diabetes, cancer and autoimmune conditions. The company also provides research services which include discovery, development and manufacturing services for both small and large molecules. Biocon caters its research and development solutions to the biotechnology and pharmaceutical companies across the world. It has an overseas manufacturing facility at BioXcell, a biotechnology park in Johor, Malaysia. Biocon is headquartered in Bangalore, Karnataka, India.

Biocon Ltd Key Recent Developments

Jul 09,2017: Biocon provides update on Bangalore Facility
Jul 09,2017: Biocon Receives GMP approval for Biologics Drug Substance facilities from French Regulator; Drug Product facility to be reinspected
Jul 09,2017: Biocon: Update on Inspection Audits by French health agency
Jun 05,2017: Biocon Appoints Ms. Pratima Rao as Mission Director of Biocon Foundation
May 10,2017: Biocon statement in response to media reports on USFDA Form 483s for Biocon Limited

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Biocon Ltd BIOCON Financial and Strategic SWOT Analysis Review [Report Updated: 18072017] Prices from USD $125


More From BioPortfolio on "Biocon Ltd BIOCON Financial and Strategic SWOT Analysis Review [Report Updated: 18072017] Prices from USD $125"

Quick Search

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...